Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3272204 A
Publication typeGrant
Publication dateSep 13, 1966
Filing dateSep 22, 1965
Priority dateSep 22, 1965
Publication numberUS 3272204 A, US 3272204A, US-A-3272204, US3272204 A, US3272204A
InventorsArtandi Charles, Bechtol Lavon Dee
Original AssigneeEthicon Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US 3272204 A
Abstract  available in
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Sept 13, 1966 .2 c. ARTANDI ETAL 3,272,204

ABSORBABLE COLLAGEN PROSTHETIC IMPLANT WITH NON-ABSORBABLE REINFORCING STRAND-S Original Filed March 1, 1961 2 Sheets-Sheet 1 INVENTORS. (Iv m2 E5 /4 P74/VD/ Ara/v 052-" (554W 704.

ATTO R N EY pt. 13, 1966 c. ARTANDI ETAL 3,272,204

ABSORBABLE COLLAGEN PROSTHETIC IMPLANT WITH NON-ABSORBABLE REINFORCING STRANDS Original Filed March 1, 1961 2 Sheets-Sheet 2 INVENTOR'S. (7 4/6455 4/? r4/v0/ Zmgo /v 0E6 550/;

ATTORNEY United States Patent 3,272,204 ABSDRISABLE CDLLAGEN PRGSTHETIC IM- PLANT WITH NON-ABSOABLIE REIN- FORQTNG STRANDS Charles Artandi, Highiand Park, N..I., and Lavon Dee Bechtel, Indianapolis, Ind., assignors to Ethicon, Inc., a corporation of New Jersey Continuation of application Ser. No. 92,620, Mar. 1, 1961. This application Sept. 22, 1965, Ser. No. 495,010 Claims. (Cl. 128334) This application is a continuation of copending application Serial No. 92,620, filed March 1, 1961, now abandoned.

The present invention relates to reinforced collagen prostheses adapted to be placed permanently in the human body, and to a method of making the same. More particularly, this invention relates to collagen articles that are reinforced with non-absorbable fabrics.

In the surgical repair of hernias, tantalum gauze and inert fabrics have found considerable use, particularly in older patients who are recognized to have a reduced ability to rebuild tissue at the point of surgery. Tantalum gauze, however, has the undesirable property of work hardening and may curl up within the body, causing discomfort. Inert fabric prostheses have the disadvantage that they do not becomea part of the body tissues. Such inserts frequently remain surrounded by a pool of sera after the healing process. A suitable prostheses for strengthening the repair should be non-toxic, flexible and porous. The ideal prostheses should retain its strength permanently in intimate contact with body fluids and should be readily accepted and incorporated into the tissue. Porosity is an important characteristic of such a prosthesis to avoid the formation of fluid pockets and to promote the growth through the fabric of repair tissue.

The present invention has for its principal object the provision of flexible films and tubes constructed of collagen and reinforced with an open mesh, non-absorbable fabric that is compatible with the human body.

A further object of the invention is the provision of such flexible tubes that are not subject to kinking or collapsing in any desired diameter or length suitable for use with human arteries or veins.

Another object is the manufacture of prostheses having a structure which promotes the growth of body tissue into and through the prostheses during the healing process.

It has now been discovered that an improved prostheses can be constructed using as a framework or support a non-absorbable plastic material, knitted, woven or braided to have a wide mesh, thus permitting easy invasion by the host into the interstices between the non-absorbable fibers. In the improved prostheses of the present invention, the interstices between the non-absor-bable fibers are initially filled and rendered blood tight by collagen fibrils. The collagen fibrils have considerable tensile strength, are non-antigenic, are slowly absorbed and permit satisfactory in-growth of fibroblasts and endothelial cells, resulting in attachment of the prosthesis to the host tissues. Since collagen is the type of connective tissue normally laid down by the body during the healing process, there is no appreciable decrease in the strength of the prosthesis during the period that the collagen fibrils are being replaced.

The invention will appear more clearly from the following detailed description when taken in connection with the accompanying drawings, showing by way of example, a preferred embodiment of the inventive idea. Referring now to the drawings:

FIGURE 1 is a view of a reinforced collagen film. In this view, the surface collagen films have been forcibly ice pulled away from the n-on-absorbable fabric to illustrate the laminated construction.

FIG. 2 is a greatly enlarged view of the non-absorbable fabric that forms the reinforcing central element of the structure illustrated by FIG. 1.

FIG. 3 is a view of a fabric mesh tube reinforced with a plastic helix.

FIG. 3a is a view in section of a fabric mesh tube reinformed with a plastic helix on the line 3a-3a of FIG. 3.

FIG. 3b is a large scale fragmentary sectional view of FIG. 3 showing a method of supporting a fabric tube in accordance with a feature of the instant invention.

FIG. 4 is a view, partially in section, of a fabric mesh tube reinforced with plastic rings and coated with collagen fibrils.

FIG. 5 is a view, partially in section, of a reinforced molded collagen tube.

The non-absorbable fabric that is used to reinforce the collagen prostheses of the present invention may be knit, woven, crocheted or braided in the desired shape of any synthetic or natural fibers that are compatible with the human body. Examples of suitable materials are Vinyon-N, a resin manufactured by the Carbide and Carbon Corporation by copolymerizing vinyl chloride and acrylonitrile; nylon, a polyamide resin made by polymerization of the hexamethylene diamine salt of adipic acid; Orlon, a synthetic fiber made by the E. I. du Pont de Nemours & Go, from polyacrylonitrile; Dacron, a synthetic fiber made by the E. I. du Pont de Nemours & Go, from terephthalic acid and ethylene glycol; Teflon, a tetrafluoroethylene polymer manufactured by the E. I. du Pont de Nemours & 00.; cotton and silk. Dacron and T efion are particularly preferred because both have displayed excellent retention of tensile strength over long periods of time and both are essentially inert. Teflon being slightly more inert and slightly stronger than Dacron.

The non-absorbable fabrics may be knitted, crocheted, woven or braided in the shape of the desired prosthesis as a film, tube, Y-tube, et-c. Optionally, a film of the fabric may be rolled or cut and sewed with suitable thread to form the desired shape. The fabric may be further strengthened by plastic rings as illustrated in FIG. 4. It is important that the mesh of the non-absorbable fabric be sufficiently open to permit the collagen fibrils to extend into and through the interstices of the fabric. These collagen fibrils that pass through the fabric cohere to the collagen fibrils on either side of the fabric framework and form a unitary structure that resists delamination.

After the fabric framework has been constructed in the desired shape, it is coated on both sides with a collagen mass obtained by swelling collagen fibrils in an aqueous acid solution. The swollen collagen fibrils are then frozen in position and deswollen by dehydration in an organic solvent.

The improved prostheses of the present invention may also be manufactured by an alternate process consisting of knitting, weaving, crocheting or braiding together an inert non-absorbable thread or yarn with collagen yarn or collagen multifilament. A suitable fabric can be woven with warp yarns of Dacron or Teflon and filling yarns of collagen. The preparation of a collagen multifilament suitable for such use is described in United States patent application Serial No. 768,969, filed October 22, 1958, abandoned in favor of continuing appli cation Serial No. 102,533, filed April 12, 1961, now Patent No. 3,114,372.

It will be understood that the collagen present in the prostheses of the present invention may be treated with tanning agents such as formaldehyde, pyrogallol, chromium, etc., by methods well known in the art to obtain increased strength and control the rate at which the collagen will be absorbed.

The present invention is more fully described and exemplified in the following examples. It is to be understood, however, that our invention is not to be limited to any specific form of materials or conditions set forth n the examples, but is limited solely by the description in this specification and the appended claims. Throughout the specification and the examples which follow, all quantities are expressed in parts by weight.

EXAMPLE I The deep flexor tendon of cattle is cleaned of fat, superficial non-collagenous protein and other extraneous matter and is Sliced on an electric meat-slicing machine (rotary knife) in the frozen condition. The tendon sections are sliced perpendicularly to their longitudinal axis to a thickness of about 11 mils. An aliquot sample of the tendon slices is analyzed; the dry solids amounts to The sliced tendon is next treated with an enzyme solution to dissolve elastin. The enzyme solution is prepared by dissolving 0.15 part of ficin and 3.75 parts of ethylene diamine tetrasodium tetraacetate in 750 parts of water. Seventy-five parts of the sliced tendon is immersed in this solution which is stored at room temperature overnight. Then 2.25 parts of 30% hydrogen peroxide is added to destroy any residual ficin.

To this mixture of tendon slices in about 750 parts of water is added an additional 2244 parts of water and 5.87 parts of cyanoacetic acid. The swelling solution is cooled to below 25 C. This mixture is stirred in a dispersion kettle at about 60 r.p.m. The remaining steps in the proceSs are carried out at temperatures below about 25 C. and the temperature of the collagen dispersion is not allowed to exceed this temperature.

Stirring is continued for about 3 hours, during which time the individual collagen slices are swollen. The dispersion is then homogenized by repeated passes through series-connected jets having orifices of 50 mils and 40 mils respectively. The dispersion is then forced through a leaf filter containing three screens of #316 stainless steel. These screens are separated by Aa-inch spacers and decrease in mesh size so that the dispersion first passes a 14- mil screen, then a 9-mil screen, and finally a 4-mil screen. The dispersion of swollen solvated collagen fibrils so obtained analyzes 1.09% solids and has a pH of 2.52.

The above collagen dispersion (300 grams) is poured into a stainless-steel tray measuring x 9" x 1 /2" and smoothed out. A Dacron tulle is placed flat on the surface of the collagen dispersion and covered with another 300 grams of collagen dispersion. The tray is frozen in a sub-zero cabinet at C. overnight. The frozen sandwich is then removed from the tray and immersed in a circulating bath containing 5 liters of 99% isopropanol and milliliters of concentrated ammonium hydroxide at room temperature. After approximately four hours, the isopropanol solution is replaced with 5 liters of a fresh solution and the dehydration is continued overnight at room temperature. The isopropanol solution containing the water extracted is removed and a third bath of 99% isopropanol is used in the further dehydration of the collagen. The third bath is replaced in turn with a fourth bath of 99% isopropanol containing 0.4% formaldehyde, the dehydrating time amounting to 6 to 8 hours in both the third and fourth baths. At this time, the collagen fibrils are practically free of water and the Dacron-collagen film may be squeezed repeatedly between rubber rollers and air-dried in an oven at C. overnight without damage.

The product so obtained is illustrated in FIGURE 1. The collagen fibrils of the surface coatings 11 and 12 extend through the openings 13 in the fabric 14 and make it difficult to separate the collagen layer from the fabric.

4 EXAMPLE II A collagen dispersion is prepared according to the general procedure described in Example I above from 391 parts of sliced beef leg tendon and 17,110 parts of distilled Water containing 7.3 parts of glacial acetic acid. This dispersion contains 0.8% solids and is placed in trays and reinforced by immersing a Teflon fabric in the dispersion so that the fabric is suspended about halfway between the sur-face of the dispersion and the bottom of the tray. The contents of each tray is frozen and transferred in the frozen condition to a wire mesh frame. The frozen mass from each tray is dehydrated and coagulated by immersing in a circulating bath containing 60,000 parts of 99% isopropanol, 300 parts of concentrated ammonium hydroxide and 240 parts of formaldehyde (37% solution) at room temperature for approximately 8 hours. The circulating isopropanol bath is then replaced with a freshly constituted bath and the dehydration is continued overnight. This second bath is replaced with a third bath containing 99% isopropanol at room temperature and the dehydration is continued for 8 to 16 hours after which a fourth bath consisting of 99% isopropanol is substituted for the third bath. After dehydration for 8 to 16 hours in the fourth bath, the collagen coated Teflon fabric is compressed at about 128 pounds per square inch pressure and air-dried at C. overnight.

EXAMPLE III Example II above was repeated, substituting for the 7.3 parts of glacial acetic acid employed in that example 59.5 parts of cyanoacetic acid. The resulting prosthesis is sterilized by electron beam irradiation and may be used by the surgeon for hernia repair.

EXAMPLE IV A collagen dispersion is prepared according to the general procedure described in Example I above from 216 parts of sliced beef leg tendon and 9,780 parts of distilled water containing 50 parts of malonic acid. This dispersion contains 0.8% solids and is used to coat both sides of a Teflon net fabric as described in Example I. The Teflon-collagen composition is frozen and transferred in the frozen condition to a wire mesh frame. The frozen mass is dehydrated and coagulated by immersing in a circulating bath containing 45,000 parts of 99% isopropanol and 1330 parts of concentrated ammonium hydroxide at room temperature for approximately 8 hours. The freshly constituted bath and the dehydration is continued overnight. This second bath is replaced with a third bath containing 99% isopropanol at room temperature and the dehydration is continued for 8 to 16 hours after which a fourth bath consisting of 99% isopropanol is substituted for the third bath. After dehydration in the fourth bath for 8 to 16 hours, the resulting product is air-dried at 50 C. overnight.

The film so obtained is tanned by immersing for 30 seconds 1n a solution of 0.4 part of pyrogallol, 0.1 part tetrasodium ethylenediamine tetraacetic acid and 99.5 parts of water adjusted to pH 8.3 with ammonium hydrox- 1de and redried in an oven at 50 C. for 6 hours.

The film is next immersed for 30 seconds in a solution .of chromium (III) sulfate comprising 0.8 part of chromium as chromic oxide, 0.5 part of lactic acid 0.24 part of formaldehyde and 98.46 parts of water adusted to pH 2.7 with sodium hydroxide, and dried in an oven at 50 C. overnight.

EXAMPLE V A glass tube having an inside diameter of about /1 inch is fitted With a one-hole stopper of rubber through which a A -inch glass rod is placed so that the glass rod extends coaxially within the glass tube. Before placing the glass rod and rubber stopper in position, the glass rod is covered With a piece of rubber tubing and a cylindrical tube of open-mesh woven Dacron about inch in diameter is slipped over the glass rod and rubber tube.

The glass tube and glass rod are assembled in an upright position with the bottom of the Dacron fabric tube resting on the rubber stopper. A dispersion of swollen collagen fibrils (0.08% collagen in 0.05 N acetic acid) is poured into the glass tube while maintaining the fabric tube in a coaxial position and equally spaced between the rubber tube and glass tube so that both sides of the fabric are coated with the collagen dispersion. This mold with the dispersion and fabric in place is then frozen in the vertical position for at least 4 hours at C.

The mold is then placed in a static coagulation bat-h consisting of 2 liters of isopropanol alcohol, cubic centimeters of concentrated ammonia (25%) and 10 cubic centimeters of formaldehyde (37% solution) at room temperature and the mold is maintained in the solution for 16 hours. The glass rod covered with the rubber tube and the formed collagen tube is then removed and placed in a dehydrating bath consisting of 2 liters of isopropanol alcohol. The collagen tube is left in this bath for an additional 16 hours to complete the dehydration.

After dehydration, the rubber tube with the collagen tube on it, is very carefully slid off the glass rod and the rubber tube is removed from the interior of the collagen tube by pulling 'on both ends of the rubber tube, thereby stretching the rubber tube and reducing its diameter. After the collagen tube is removed from the rubber tubing, it is plasticized in a bath consisting of 2 liters of 90% isopropanol alcohol (10% water) containing 5% glycerine. This plasticizing operation is optional. After 24 hours in the plasticizing bath, the collagen tube is supported on a glass rod and air-dried. The resulting product is illustrated in FIGURE 5.

EXAMPLE VI Tanned Dacron reinforced collagen films prepared by the method described in Example II above are rolled and sewed to form tubes about 1 centimeter in diameter and sterilized by irradiating with an electron beam. These tubes are used to replace segments of the abdominal aorta in mongrel dogs averaging 15 kilograms in weight. The animals were sacrificed at varying periods of time up to 8 months.

Grossly, the Dacron-collagen prothesis shows an orderly pattern of organization at varying periods of time following insertion of the graft. The prostheses are all 5 centimeters long, divided into two typesthick and thin,

according to the amount of impregnated collagen. N0 significant response difference can be detected in the two types. However, there is a significant difference, particularly in regard to initial hemorrhage, between the untreated collagen and the collagen that has been tanned. The following results are observed:

One week Gross specimen-The one-week specimens are contained in a fibrous envelope which is not in any Way adherent to the prosthesis. The interstices of the graft are still occlude-dby the impregnated collagen and the lumen is lined by a red, granular coagulum.

Microscopic section.Sections of the proximal portion show an artefactual separation of the Dacron prosthesis from the surrounding fibro-adipose tissue.

The fibre-adipose tissue shows active fibroplasia and a minimal inflammatory infiltrate, comprised of polymorphonuclear leukocytes, a few lymphocytes and some plasma cells. The prosthesis itself shows the open meshwork with the interstices filled by a series of haphazardlyarranged, tangled fibrils of bovine collagen with irregular interstices containing small numbers of erythrocytes. The surface of the prosthesis is covered by fibrin clot containing a few histiocytes, erythrocytes and neutrophils. There is no tongue-like extension of fibroplasia extending from the severed end of the aorta out into the graft, although there is a focal zone of reactive hyperplasia with capillaries and occasional inflammatory elements present at the anastomotic line. The lining consists of a thin fibrin layer, maximally 1 millimeter in thickness.

Two weeks Gross specimen.By two weeks, the fibrous envelope is partially adherent but may be readily dissected free by lysis of delicate fibrous and fibrinous bands. The wall of the prosthesis and the lining are similar to those of the one-week specimen.

Microscopic seclion.-The two-week specimen shows a lack of inflammatory reaction similar to the specimen at one week. The zone of fibrosis and fibroplasia in the fibro-adipose tissue adjoining the prosthesis is more mature, but as yet, there is no extension of fibroblasts into the prosthesis except at microscopic points. At the anastomosis, a well developed zone of fibroplasia extends across the anastomotic line onto the surface of the prosthesis and this tongue, in turn, is covered in part by endothelium. The prosthesis itself appears quite similar to the oneweek specimen. The impregnated collagen appears well retained. The lining surface of the prosthesis now appears to be more dense fibrin with enmeshed erythrocytes and is somewhat thinner than the fibrin lining of the oneweek specimen.

Three weeks Gross specimen.-At three weeks the fibrous envelope is more adherent than earlier, but still may be separated by forceful dissection. The lining is smoother and averages approximately one millimeter in thickness.

Microscopic section-The peripheral enveloping zone of fibrosis is wider than previously and there is extension of fibroblasts into the interstices of the prosthesis at numerous points. Foreign body reaction to the Dacron of the prosthesis is present but still remains minimal. The inflammatory reaction is largely composed of histiocytes containing hemosiderin, plasma cells and lymphocytes. A mural fibrin thrombus is present and is focally organiZed, particularly at the anastomotic line. This organization is part of the tongue of advancing fibroblasts.

Four weeks Gross specimen.-The four-week specimen is finely swedged to the fibrous envelope. A thin semi-transparent membrane covers the anastomotic lines.

Microscopic section.A dense, surrounding fibrous envelope of mature collagenous connective tissue stains bright green in a Masson trichrome stain. The prosthesis adheres densely to this envelope and there are irregular extensions of this material into the interstitial areas of the prosthesis, most particularly between the Dacron meshwork. The interstices of the bovine collagen are now partially filled with green-staining collagenous connective tissue from the host. Inflammatory reaction is meager. The lining of the prosthesis consists of a zone of fibrous tissue apparently covered by endothelium that ranges in thickness from about 1 millimeter to less than 0.1 millimeter, being thinnest in its more central extent. This lining is continuous with the lining of the dogs aorta.

Five weeks Gross specimen-The five-week specimen is essentially the same as the four-week specimen.

Microscopic secti0n.-The appearance is substantially the same as that of the four-week specimen, although there is slightly less of the bovine collagen remaining and more of green-staining collagen contributed by the host, particularly at the anastomosis.

Two-and-a-half months Gross specimen-The organization is almost complete. The fibrous envelope is firmly adherent and the lumen is lined by a thin, well-defined, smooth, semi-transparent grayish membrane.

Microscopic section-There is notable progress of the fibrous tissue ingrowth into the prosthesis. Only an occasional, longitudinally, oriented wavy thread of the original prosthetic impregnation remains.

Eight months Gross specimen.The prosthesis is solidly united to the fibrous envelope. In cross section, the entire thickness of the prosthetic wall is slightly less than 2 millimeters. The lumen is covered by a smooth, glistening, grayish membrane that appears continuous with the intima of the host artery.

Microscopic section.The prosthesis is completely organized by mature collagen that fills all of the interstices and has replaced all of the original bovine collagen fibrils except for a rare remaining fibril. The luminal aspect of the prosthesis is smooth and is continuous with the dogs aorta. There is virtually no inflammatory reaction. The Dacron material of the prosethetic meshwork appears embedded in a continuous, rather uniform collagen mass. Externally, the prosthesis blends with the adjoining fibroadipose tissue.

EXAMPLE VII A Teflon fabric 14 is rolled to form a cylinder'as indicated in FIGURE 3 and the fabric is sewed with Dacron thread 15 to a surrounding Teflon helix 16 as illustrated in FIGURE 3. The supporting helix prevents the fabric tube from kinking or collapsing. This structure is covered with collagen fibrils on both sides by the procedure outlined in Example V. The resulting tube resists fraying at the ends and is adapted for use in grafts that traverse the inguinal fold or the popliteal space.

EXAMPLE VIII A Dacron fabric 14 is sewed to form a cylinder as indicated in FIGURE 4 and the fabric is sewed with Dacron thread 15 to spaced surrounding Teflon rings 17 as illustrated in FIGURE 4. The supporting rings 17 serve the same function as the helix 16 in FIGURE 3 and prevents the fabric tube from kinking or collapsing. This structure is covered by collagen fibrils on both sides by the procedure outlined in Example V. The resulting article after electron beam sterilization is adapted for use in clinical vascular surgery. The finished tube is quite flexible and may be flexed repeatedly without collapsing.

EXAMPLE IX A collagen dispersion (0.86% solids) is extruded into a circulating acetone dehydrating bath through a stainless steel spinnerette drilled with 192 openings arranged in concentric circles. Each opening in the spinnerette is approximately 18 mils in diameter and each opening has a taper from this diameter at a point 34 mils from the spinnerette surface to a inch opening at the bottom surface of the spinnerette. The multifilament that emerges from the acetone dehydrating bath is wrapped 1 /2 times around a godet and passes to a false twister. Warm air is circulated to dry out the multifilament as it contacts the false twister which is rotated at about 200 r.p.m. Under these conditions, the individual filaments that make up the multifilament do not bond together. The multifilament, which consists of 192 individual collagen threads, may be collected directly on a takeup spool.

The collagen multifilament so obtained may be woven together with non-absorbable multifilament or yarn such as Dacron yarn to form fabrics and tubes that are useful in surgery. It is desirable that the collagen multifilament be tanned by methods well-known in the art to increase the strength and in vivo digestion time of the collagen. The collagen multifilament may be tanned prior to or after weaving. If the collagen multifilament is tanned prior to weaving, a collagen strand may conveniently be formed by twisting the collagen multifilament and drying under tension. Under these conditions, the individual filaments cohere to form a strand which may be woven into a fabric or tube with non-absorbable threads or yarn.

While the invention has been described in detail according to the preferred method of carrying out the process and yielding the products, it will be obvious to those skilled in the art, after understanding the invention, that changes and modifications may be made (without departing from the spirit or scope of the invention) and it is intended in the appended claims to cover such changes and modifications.

What is claimed is: 1. A method of manufacturing surgical prostheses which comprises the steps of:

impregnating a non-absorbable fabric with an aqueous acid dispersion of swollen collagen fibrils; freezing the aqueous acid dispersion of swollen collagen fibrils; immersing the frozen mass in a water-miscible organic solvent containing sufficient base to neutralize the acid present in said dispersion; removing the resulting structure from the organic solvent; and, drying the resulting structure. 2. A method of manufacturing surgical prostheses which comprises the steps of:

knitting an open mesh tube; impregnating this tube with an aqueous acid dispersion of collagen fibrils, whereby said collagen fibrils fill the interstices of the tube; freezing the aqueous acid dispersion of collagen fibrils; immersing the frozen mass in acetone containing suflicient ammonium hydroxide to neutralize the acid present in said dispersion, whereby the collagen fibrils are dehydrated and coagulated; removing the structure so obtained from the acetone;

and, drying. 3. A surgical prosthesis comprising: an open mesh non-absorbable fabric, manufactured of material selected from the group consisting of polyethylene terephthalate and tetra fluoroethylene polymer, and impregnated with a body absor-bable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight. 4. -A surgical prosthesis comprising: an open mesh non-absorbable tulle, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, the interstices of which are filled with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight. 5. A surgical prosthesis comprising: an open mesh non-absorbable cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on at least one side with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

A surgical prosthesis comprising:

a knit open mesh non-absorba'ble cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on at least one side with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

7. A surgical prosthesis comprising:

a woven open mesh non-absorbable cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on both sides with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

'8. A surgical prosthesis comprising:

a non-absorbable tulle, manufactured of material selected from the group consisting of polyethylene t r phthalate and tetrafluoroethylene polymer, and

shaped to form a cylindrical tube; a plurality of reinforcing non-absonbable rings manufactured of tet rafiuoroethylene polymer surrounding and spaced along the axis of said tube; said tube being encapsulated in a matrix of collagen fibrils.

9. A surgical prosthesis comprising:

a non-absorbable fabric, manufactured of material selected from the group consisting of polyethylene terephthalate and tetraifluoroethylene polymer fabrics, and shaped to form a cylindrical tube; a nylon helix coiled around said tube; the tube and surrounding helix being coated with collagen fibrils.

10. A surgical prosthesis comprising a bloodtight knitted fabric consisting of a non absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafluoroethylene polymer yarn and mixtures thereof; and a body absonbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

1 1. A surgical prosthesis comprising a bloodtight fabric woven with filling yarns of non-absorbable threads selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer threads; and Warp yarns of body absorbable extruded strands consisting of collagen fibrils, the non-absorbable threads of the fabric being separated sufficiently from each other to permit easy invasion by the host tissue during the healing process.

12. A surgical prosthesis comprising a bloodtight fabric woven with tfilling yarns of non-absorbable threads selected from the group consisting of polyethylene terephthalate and tetrafluoroethy-lene polymer threads; and Warp yarns of a body absorbable extruded multifilamen-t consisting of collagen fibrils, the interstices between the nonabsorbable threads of the fabric being sufficiently lange to permit easy invasion by the host tissue during the healing process.

1 3. A surgical prosthesis comprising a bloodtight woven fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafiuoroethylene polymer yarn and mixtures thereof; and a body absorbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorb able yarn of the fabric being sufliciently large to permit easy invasion by the host tissue during the healing process.

14. A surgical prosthesis comprising a bloodtight braided fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafiuoroethylene polymer yarn and mixtures thereof; and a body absorbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

15. A surgical prosthesis comprising a bloodtight crocheted fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafluoroethy lene polymer yarn and mixtures thereof; and a body absonbable extruded multifilament consisting of collagen fibrils, the interstices between the non-a-bsorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

References Cited by the Examiner UNITED STATES PATENTS 2,072,302 3/ 1937 Hermann et al 12'8-335 .5 2,127,903 8/ 1938 =Bowen 128-334 2,453,056 11/1948 Zack 128-334 2,667,321 5/1953 Cresswell 128- 3355 2,671,444 3/ 1954 Pease 128-455 X 2,731,788 1/1956 Donaldson 2 8-7 6 2,827,359 3/1958 Kine et al 28-80 X 2,845,959 8/1958 Sidebotham 31 X 2,920,000 1/ 1960 Hochstadt et al. 260- 123] X 2,934,447 4/1960 Highbenger et al. 106-155 3,011,527 1 2/ 1961 Corbiere 1 393-87 3,014,024 12/ 1961 Lieberman et al. 260-l23.7

OTHER REFERENCES Progress in Synthetic Graft Development, Surgery, vol.

45, No. 2, pp. 298 309, February 1959.

RICHARD A. GAUDET, Primary Examiner.

D. L. TRULUOK, Assistant Examiner.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,272,204 September 13, 1966 Charles Artandi et a1.

ppears in the above numbered pat- It is hereby certified that error a aid Letters Patent should read as ent requiring correction and that the s corrected below.

Column 4 line 46, after. "The" insert circulating isopropanol bath is then replaced with a Signed and sealed this 1st day of August 1967.

(SEAL) Attest:

EDWARD J. BRENNER Commissioner of Patents Edward M. Fletcher, Jr. Attesting Officer

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2072302 *Mar 3, 1932Mar 2, 1937Chemische Forschungs GmbhPolymerized vinyl alcohol articles and processes of making same
US2127903 *May 5, 1936Aug 23, 1938Davis & Geck IncTube for surgical purposes and method of preparing and using the same
US2453056 *Mar 12, 1947Nov 2, 1948Edwin Zack WilliamSurgical anastomosis apparatus and method
US2637321 *Sep 27, 1951May 5, 1953American Cyanamid CoShaped article and method of producing it
US2671444 *Dec 8, 1951Mar 9, 1954Pease Jr Benjamin FNonmetallic mesh surgical insert for hernia repair
US2731788 *Oct 8, 1949Jan 24, 1956CluettComposite thread.
US2827359 *Mar 22, 1954Mar 18, 1958Rohm & HaasProcess for stabilization of protein textiles with 4-vinyl pyridine copolymers and products produced therefrom
US2845959 *Mar 26, 1956Aug 5, 1958Sidebotham John BBifurcated textile tubes and method of weaving the same
US2920000 *Oct 22, 1958Jan 5, 1960Ethicon Inc Ethicon IncRemovable valve Collagen article and the manufacture thereof
US2934447 *Oct 22, 1957Apr 26, 1960United Shoe Machinery CorpCollagen fiber masses and methods of making the same
US3011527 *May 23, 1957Dec 5, 1961RhodiacetaProsthesis consisting of textile materials
US3014024 *Mar 19, 1958Dec 19, 1961Johnson & JohnsonCollagen film
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3366440 *Nov 3, 1964Jan 30, 1968Ethicon IncProcess for manufacturing a collagen fabric-film laminate
US3400719 *Jun 9, 1964Sep 10, 1968Albert O.L.J. Eckhart BuddeckePlastic graft material and method of making same
US3408659 *Jul 21, 1965Nov 5, 1968Thiele HeinrichArtificial blood vessels and process of making same
US3425418 *Apr 15, 1964Feb 4, 1969Spofa Vereinigte Pharma WerkeArtificial blood vessels and method of preparing the same
US3452366 *Jun 21, 1966Jul 1, 1969Avco CorpPercutaneous conduit and connector
US3463158 *Jan 9, 1967Aug 26, 1969American Cyanamid CoPolyglycolic acid prosthetic devices
US3479670 *Oct 19, 1966Nov 25, 1969Ethicon IncTubular prosthetic implant having helical thermoplastic wrapping therearound
US3491760 *Jul 6, 1966Jan 27, 1970Braun Intern Gmbh BWound coverings
US3514791 *Jul 25, 1967Jun 2, 1970Charles H SparksTissue grafts
US3625198 *May 9, 1969Dec 7, 1971Charles H SparksDie and holder for implanting in a living body to grow tissue grafts
US3862452 *Jun 21, 1971Jan 28, 1975Ceskoslovenska Akademie VedHydrogel substitutes for tubular somatic organs
US3918099 *May 29, 1974Nov 11, 1975Fettback HelmutArtificial organ or part or section thereof for implanation into the human body and method of producing the same
US4086665 *Dec 16, 1976May 2, 1978Thermo Electron CorporationArtificial blood conduit
US4130904 *Jun 6, 1977Dec 26, 1978Thermo Electron CorporationProsthetic blood conduit
US4182339 *May 17, 1978Jan 8, 1980Hardy Thomas G JrAnastomotic device and method
US4229838 *Jul 3, 1978Oct 28, 1980Sumitomo Electric Industries, Ltd.Polytetrafluoroethylene tube, quaternized polyethylenimine, heparin
US4329743 *Apr 27, 1979May 18, 1982College Of Medicine And Dentistry Of New JerseyPolylactic acid for surgical implant
US4338926 *Nov 21, 1980Jul 13, 1982Howmedica, Inc.Bone fracture prosthesis with controlled stiffness
US4361552 *Sep 26, 1980Nov 30, 1982Board Of Regents, The University Of Texas SystemWound dressing
US4365357 *Apr 25, 1980Dec 28, 1982Merck Patent Gesellschaft Mit Beschrankter HaftungSurgical network and a prepolymer and monomer
US4411027 *Feb 23, 1982Oct 25, 1983University Of Medicine And Dentistry Of New JerseyBio-absorbable composite tissue scaffold
US4441215 *Feb 23, 1983Apr 10, 1984Kaster Robert LVascular graft
US4457028 *Oct 14, 1982Jul 3, 1984Merck Patent Gesellschaft Mit Beschrankter HaftungSurgical materials suitable for use with bone cements
US4501263 *Mar 31, 1982Feb 26, 1985Harbuck Stanley CMethod for reducing hypertension of a liver
US4512038 *Apr 6, 1981Apr 23, 1985University Of Medicine And Dentistry Of New JerseyCarbon fiber, polylactic acid composites, fractured bones
US4550447 *Aug 3, 1983Nov 5, 1985Shiley IncorporatedVascular graft prosthesis
US4647416 *Apr 26, 1985Mar 3, 1987Shiley IncorporatedMethod of preparing a vascular graft prosthesis
US4662884 *Apr 25, 1984May 5, 1987University Of Utah Research FoundationProstheses and methods for promoting nerve regeneration
US4670286 *Dec 26, 1985Jun 2, 1987Allied CorporationCoating by controlled dipping with bioresorbable, vasotropic solution
US4778467 *Jul 10, 1986Oct 18, 1988The University Of UtahProstheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4787391 *Aug 11, 1987Nov 29, 1988Elefteriades John AAnastomotic marking device and related method
US4842575 *Aug 5, 1988Jun 27, 1989Meadox Medicals, Inc.Massaging aqueous slurry of collagen and plasticizers into porous substrate; then drying and cross-linking by exposure to formaldehyde vapor
US4865031 *Oct 3, 1988Sep 12, 1989Keeffe Paul J OFabric and method of use for treatment of scars
US4871365 *Dec 24, 1986Oct 3, 1989American Cyanamid CompanyPolyglycolic acid, trimethylene carbonate linkager
US4915893 *Jul 15, 1983Apr 10, 1990Medtronic, Inc.Method of preparing polyester filament material
US4997440 *Aug 10, 1990Mar 5, 1991American Cyanamid CompanyVascular graft with absorbable and nonabsorbable components
US5098779 *Jun 25, 1990Mar 24, 1992W. L. Gore & Associates, Inc.Carvable implant material
US5108424 *Jan 28, 1991Apr 28, 1992Meadox Medicals, Inc.Collagen-impregnated dacron graft
US5110852 *Oct 27, 1988May 5, 1992Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5141522 *Jan 21, 1992Aug 25, 1992American Cyanamid CompanyBlends of nonabsorbable bioacompatible polytetrafluoroethylene with bioabsorbable polymeric fillers, high strength
US5147374 *Dec 5, 1991Sep 15, 1992Alfredo FernandezProsthetic mesh patch for hernia repair
US5178630 *May 26, 1992Jan 12, 1993Meadox Medicals, Inc.Ravel-resistant, self-supporting woven graft
US5197977 *Apr 30, 1992Mar 30, 1993Meadox Medicals, Inc.Drug delivery collagen-impregnated synthetic vascular graft
US5201745 *Aug 15, 1991Apr 13, 1993ImedexMultilayer; two layers of collagen and adhesive
US5207670 *Dec 9, 1991May 4, 1993Rare Earth Medical, Inc.Lasers, crosslinking agent
US5282823 *Mar 19, 1992Feb 1, 1994Medtronic, Inc.Intravascular radially expandable stent
US5282846 *Apr 29, 1992Feb 1, 1994Meadox Medicals, Inc.Ravel-resistant, self-supporting woven vascular graft
US5282848 *Apr 19, 1993Feb 1, 1994Meadox Medicals, Inc.Self-supporting woven vascular graft
US5282860 *Oct 8, 1992Feb 1, 1994Olympus Optical Co., Ltd.Prevents clogging
US5326355 *Aug 24, 1992Jul 5, 1994American Cyanamid CompanyBiomedical applications, tissue repair, burn and wound dressing, vascular grafts, drug delivery systems
US5383925 *Sep 14, 1992Jan 24, 1995Meadox Medicals, Inc.Three-dimensional braided soft tissue prosthesis
US5385156 *Aug 27, 1993Jan 31, 1995Rose Health Care SystemsDiagnostic and treatment method for cardiac rupture and apparatus for performing the same
US5385580 *Sep 21, 1992Jan 31, 1995Meadox Medicals, Inc.Self-supporting woven vascular graft
US5423849 *Jan 15, 1993Jun 13, 1995Target Therapeutics, Inc.Vasoocclusion device containing radiopaque fibers
US5443496 *Oct 15, 1993Aug 22, 1995Medtronic, Inc.Intravascular radially expandable stent
US5458636 *Jul 20, 1994Oct 17, 1995U.S. Biomaterials CorporationProsthetic device for repair and replacement of fibrous connective tissue
US5487858 *Jan 31, 1994Jan 30, 1996Meadox Medicals, Inc.Process of making self-supporting woven vascular graft
US5496364 *Jan 31, 1994Mar 5, 1996Meadox Medicals, Inc.Self-supporting woven vascular graft
US5509931 *Jan 28, 1994Apr 23, 1996Meadox Medicals, Inc.Ravel-resistant self-supporting woven vascular graft
US5540677 *Oct 24, 1994Jul 30, 1996Rare Earth Medical, Inc.Photopolymerizable polymer and radiation of tubular casement for surgery
US5542594 *Oct 6, 1993Aug 6, 1996United States Surgical CorporationFor driving surgical fasteners into body tissue
US5562725 *Sep 14, 1992Oct 8, 1996Meadox Medicals Inc.Radially self-expanding implantable intraluminal device
US5562946 *Nov 2, 1994Oct 8, 1996Tissue Engineering, Inc.Apparatus and method for spinning and processing collagen fiber
US5569239 *Aug 18, 1994Oct 29, 1996Rare Earth Medical, Inc.Photoreactive suturing of biological materials
US5628788 *Nov 7, 1995May 13, 1997Corvita CorporationSelf-expanding endoluminal stent-graft
US5651174 *Apr 27, 1995Jul 29, 1997Medtronic, Inc.Intravascular radially expandable stent
US5665114 *Aug 12, 1994Sep 9, 1997Meadox Medicals, Inc.Tubular expanded polytetrafluoroethylene implantable prostheses
US5693085 *Apr 26, 1995Dec 2, 1997Scimed Life Systems, Inc.Stent with collagen
US5697969 *Sep 20, 1995Dec 16, 1997Meadox Medicals, Inc.Vascular prosthesis and method of implanting
US5700269 *Nov 13, 1995Dec 23, 1997Corvita CorporationEndoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability
US5716660 *May 31, 1995Feb 10, 1998Meadox Medicals, Inc.Impregnating microvoids in prosthesis with solution of soluble, biocompatible, biodegradable material comprising extracellular matrix proteins, raising ph to precipitate in situ
US5725522 *Jun 7, 1995Mar 10, 1998Rare Earth Medical, Inc.Laser suturing of biological materials
US5741332 *Oct 19, 1995Apr 21, 1998Meadox Medicals, Inc.Three-dimensional braided soft tissue prosthesis
US5741333 *Apr 3, 1996Apr 21, 1998Corvita CorporationSelf-expanding stent for a medical device to be introduced into a cavity of a body
US5800541 *Jan 8, 1997Sep 1, 1998Collagen CorporationCollagen-synthetic polymer matrices prepared using a multiple step reaction
US5824034 *Jun 5, 1995Oct 20, 1998Meadox Medicals, Inc.Method for repositioning a radially self-expanding implantable intraluminal device
US5849037 *Apr 3, 1996Dec 15, 1998Corvita CorporationSelf-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation
US5851230 *Oct 18, 1996Dec 22, 1998Meadox Medicals, Inc.Vascular graft with a heparin-containing collagen sealant
US5851290 *May 22, 1996Dec 22, 1998Tissue Engineering, Inc.Apparatus for spinning and processing collagen fiber
US5908427 *May 30, 1997Jun 1, 1999United States Surgical CorporationSurgical stapling apparatus and method
US5911942 *Nov 2, 1995Jun 15, 1999Tissue Engineering, Inc.Method for spinning and processing collagen fiber
US5913894 *Oct 20, 1995Jun 22, 1999Meadox Medicals, Inc.Solid woven tubular prosthesis
US5964774 *Sep 12, 1997Oct 12, 1999United States Surgical CorporationSurgical stapling apparatus and method with surgical fabric
US5968091 *Nov 26, 1997Oct 19, 1999Corvita Corp.Stents and stent grafts having enhanced hoop strength and methods of making the same
US5972007 *Oct 31, 1997Oct 26, 1999Ethicon Endo-Surgery, Inc.Energy-base method applied to prosthetics for repairing tissue defects
US6042592 *Aug 4, 1997Mar 28, 2000Meadox Medicals, Inc.Thin soft tissue support mesh
US6045560 *Jun 17, 1996Apr 4, 2000United States Surgical CorporationSurgical stapling apparatus with biocompatible surgical fabric
US6090137 *Feb 5, 1999Jul 18, 2000Meadox Medicals, Inc.Solid woven tubular prosthesis methods
US6090996 *Aug 4, 1997Jul 18, 2000Collagen Matrix, Inc.Implant matrix
US6120539 *May 1, 1997Sep 19, 2000C. R. Bard Inc.Prosthetic repair fabric
US6162247 *Dec 21, 1998Dec 19, 2000Meadox Medicals, Inc.Providing a stable collagen-heparin dispersion and applying the same to the synthetic vascular prosthesis to effectuate sealing and impart anti-thrombogenic properties thereto
US6177609 *Mar 10, 1997Jan 23, 2001Meadox Medicals, Inc.Biocompatible aqueous slurry for forming fluid-tight barrier on surface of porous implantable prosthesis; a cryogenically milled protein comminutate of uniform particle size; highly controlled viscosity and solubility; protective coatings
US6197296Mar 29, 1994Mar 6, 2001National Heart Research FundForming a contracted gel from an aqueous mixture of collagen fibrils, a nutrient medium and a cellular contractile agent, lining the gel with endothelial cells to obtain tissue equivalent, applying aqueous fluid to tissue
US6228111Sep 27, 1996May 8, 2001Bionx Implants OyFirst and second degradation and detaching times over longitudinal axis
US6237460Apr 30, 1998May 29, 2001Corvita CorporationMethod for preparation of a self-expanding stent for a medical device to be introduced into a cavity of a body
US6251110Mar 31, 1999Jun 26, 2001Ethicon Endo-Surgery, Inc.Combined radio frequency and ultrasonic surgical device
US6257241Mar 31, 1999Jul 10, 2001Ethicon Endo-Surgery, Inc.Method for repairing tissue defects using ultrasonic radio frequency energy
US6258124May 10, 1999Jul 10, 2001C. R. Bard, Inc.Prosthetic repair fabric
US6270530Jun 9, 2000Aug 7, 2001C.R. Bard, Inc.Prosthetic repair fabric
US6273897Feb 29, 2000Aug 14, 2001Ethicon, Inc.Surgical bettress and surgical stapling apparatus
US6287344Mar 31, 1999Sep 11, 2001Ethicon Endo-Surgery, Inc.Method for repairing tissue defects using an ultrasonic device
US6296645Apr 9, 1999Oct 2, 2001Depuy Orthopaedics, Inc.Intramedullary nail with non-metal spacers
US6325810Jun 30, 1999Dec 4, 2001Ethicon, Inc.Foam buttress for stapling apparatus
US6334872 *Jul 7, 1997Jan 1, 2002Organogenesis Inc.Method for treating diseased or damaged organs
US6348065Jul 24, 1998Feb 19, 2002Scimed Life Systems, Inc.Longitudinally flexible expandable stent
US6350277Jan 15, 1999Feb 26, 2002Scimed Life Systems, Inc.Stents with temporary retaining bands
US6368347 *Apr 23, 1999Apr 9, 2002Sulzer Vascutek Ltd.Uniform coating of bioresorbable gel material on an outer surface. the coating minimizes bleeding through suture holes in the eptfe sheet and an increase in longitudinal extensibility.
US6375662Nov 23, 1999Apr 23, 2002Scimed Life Systems, Inc.Thin soft tissue surgical support mesh
US6391052Oct 29, 1997May 21, 2002Scimed Life Systems, Inc.Immersion in aqueous electrolytes; electrodeposition of coating on metal surface
US6416486Mar 31, 1999Jul 9, 2002Ethicon Endo-Surgery, Inc.Ultrasonic surgical device having an embedding surface and a coagulating surface
US6488705Sep 18, 2001Dec 3, 2002Meadox Medicals, Inc.Radially self-expanding implantable intraluminal device
US6497650Jul 28, 2000Dec 24, 2002C. R. Bard, Inc.Hernia prosthesis
US6524345Oct 22, 1997Feb 25, 2003Bionx Implants OySurgical implant
US6572650Jun 4, 1999Jun 3, 2003Organogenesis Inc.Bioengineered vascular graft support prostheses
US6652595Jan 9, 1998Nov 25, 2003Davol Inc.Method of repairing inguinal hernias
US6669706Dec 18, 2001Dec 30, 2003Scimed Life Systems, Inc.Thin soft tissue surgical support mesh
US6709436May 22, 2000Mar 23, 2004Depuy Orthopaedics, Inc.Non-metal spacers for intramedullary nail
US6726664 *Aug 6, 2001Apr 27, 2004Optonol Ltd.Flow control device, introducer and method of implanting
US6770088May 18, 2000Aug 3, 2004Scimed Life Systems, Inc.Intravascular stent
US6783529Oct 19, 2001Aug 31, 2004Depuy Orthopaedics, Inc.Non-metal inserts for bone support assembly
US6786908Aug 2, 2001Sep 7, 2004Depuy Orthopaedics, Inc.Bone fracture support implant with non-metal spacers
US6790213Jan 7, 2002Sep 14, 2004C.R. Bard, Inc.Promotes tissue growth into the prosthesis and subsequently strengthens the area of the defect, such as tissue or muscle defect
US6808527Mar 25, 2002Oct 26, 2004Depuy Orthopaedics, Inc.Intramedullary nail with snap-in window insert
US6818014Aug 3, 1995Nov 16, 2004Scimed Life Systems, Inc.Longitudinally flexible expandable stent
US6827743 *Feb 25, 2002Dec 7, 2004Sdgi Holdings, Inc.Woven orthopedic implants
US6846323May 15, 2003Jan 25, 2005Advanced Cardiovascular Systems, Inc.Intravascular stent
US6890351 *Sep 7, 2001May 10, 2005Organogenesis Inc.Method for treating diseased or damaged organs
US6913619Jul 11, 2002Jul 5, 2005Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US6929659Feb 25, 2002Aug 16, 2005Scimed Life Systems, Inc.Method of preventing the dislodgment of a stent-graft
US6962603Jun 22, 2000Nov 8, 2005Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US6976952Apr 25, 2000Dec 20, 2005Vascutek LimitedExpanded polytetrafluoroethylene vascular graft with coating
US6981986Sep 20, 2000Jan 3, 2006Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US6986735Mar 3, 2003Jan 17, 2006Organogenesis Inc.Method of making a bioremodelable vascular graft prosthesis
US7022132Feb 26, 2002Apr 4, 2006Boston Scientific Scimed, Inc.Stents with temporary retaining bands
US7041131Apr 11, 2003May 9, 2006Organogenesis, Inc.implanting collagen tube as external support for grafted blood vessel by performing anastomosis of blood vessel graft to host blood vessel, passing blood vessel graft through collagen tube comprising layer of processed tissue matrix derived from tunica submucosa of small intestine; tissue engineering
US7044982Aug 27, 2001May 16, 2006Michael MilbockerSurgical repair of tissue defects
US7060103Feb 28, 2003Jun 13, 2006Organogenesis Inc.Tissue repair fabric
US7081130Apr 16, 2002Jul 25, 2006Boston Scientific Scimed, Inc.Intravascular Stent
US7121999Mar 3, 2003Oct 17, 2006Organogenesis Inc.Layering two or more sheets of hydrated processed tissue matrix;dehydrating layers to adhere the layers together;crosslinking layers; rinsing, mechanically cleaning the layers of tissue matrix chemically cleaning the layers of tissue matrix; contacting the tissue matrix with an acid containing a salt
US7156804Dec 2, 2002Jan 2, 2007Davol, Inc.Hernia prosthesis
US7160333Sep 5, 2003Jan 9, 2007Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US7163563Jul 15, 2002Jan 16, 2007Depuy Products, Inc.Unitary surgical device and method
US7201917Jul 15, 2002Apr 10, 2007Depuy Products, Inc.Particles suspended in matrix
US7204848Nov 20, 1998Apr 17, 2007Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US7214242Mar 3, 2003May 8, 2007Organogenesis, Inc.Bioengineered tubular graft prostheses
US7326241Aug 9, 2001Feb 5, 2008Boston Scientific Scimed, Inc.Intravascular stent
US7341601Jul 28, 2004Mar 11, 2008Warsaw Orthopedic, Inc.Woven orthopedic implants
US7354627Dec 22, 2004Apr 8, 2008Depuy Products, Inc.Method for organizing the assembly of collagen fibers and compositions formed therefrom
US7404819Sep 14, 2000Jul 29, 2008C.R. Bard, Inc.Implantable prosthesis
US7410488Feb 18, 2005Aug 12, 2008Smith & Nephew, Inc.Hindfoot nail
US7468210Dec 10, 2003Dec 23, 2008Biosurface Engineering Technologies, Inc.Immersing the medical device comprising polytetrafluoroethylene in is bis-(benzotriazole carbonate) polyethylene glycol, immersing in crsslinkable chondroitin sulfate, heparan sulfate and heparin bonded to Dodecyldimethylsilylmethyl carbamate compound to provide thromboresistant coating
US7481816Oct 27, 2003Jan 27, 2009Optonol Ltd.Intraocular implant, delivery device, and method of implantation
US7513865Dec 20, 2005Apr 7, 2009Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US7513866Oct 29, 2004Apr 7, 2009Depuy Products, Inc.Intestine processing device and associated method
US7569233Apr 20, 2005Aug 4, 2009Depuy Products, Inc.laminating a bioprosthetic device with a synthetic layer positioned between two natural extracellular matrix; soft tissue attachment, reinforcement, reconstruction; small intestine submucosa; tissue repair and regeneration of connective tissue
US7585319 *Sep 27, 2004Sep 8, 2009Maquet Cardiovascular, LlcBiocompatible aqueous slurry for hermetic sealing barriers on medical equipment
US7595062Jul 28, 2005Sep 29, 2009Depuy Products, Inc.Orthopedic implant of self-assembled porous structure comprising a collagen type I matrix in its native alpha-helical structure, and a sheet of naturally occurring submucosal matrix secured thereto; sponge as scaffold for tissue repair
US7614258Oct 19, 2006Nov 10, 2009C.R. Bard, Inc.Prosthetic repair fabric
US7655009Nov 30, 2004Feb 2, 2010Smith & Nephew, Inc.Humeral nail
US7670310Dec 7, 2007Mar 2, 2010Optonol LtdFlow regulating implants
US7682392Oct 30, 2002Mar 23, 2010Depuy Spine, Inc.Regenerative implants for stabilizing the spine and devices for attachment of said implants
US7700563Aug 19, 2003Apr 20, 2010Biosurface Engineering Technologies, Inc.Synthetic heparin-binding factor analogs
US7766956Nov 26, 2003Aug 3, 2010Boston Scientific Scimed, Inc.Intravascular stent and assembly
US7799089Oct 10, 2006Sep 21, 2010Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US7815562Aug 11, 2005Oct 19, 2010Boston Scientific Scimed, Inc.Tubular implantable sling and related delivery systems, methods and devices
US7819918 *Dec 29, 2003Oct 26, 2010Depuy Products, Inc.Implantable tissue repair device
US7820172Jun 1, 2007Oct 26, 2010Biosurface Engineering Technologies, Inc.including a heparin-binding peptide sequence covalently linked to a linker sequence; useful for coating medical devices and as soluble biologics, and as pharmaceutical agents for treating a variety of conditions
US7824420May 26, 2004Nov 2, 2010C.R. Bard, Inc.Implantable prosthesis
US7824701Feb 25, 2003Nov 2, 2010Ethicon, Inc.from monomers such as lactide, glycolide, dioxanone, and caprolactone; living cells migrate and populate scaffold; orthopedics, foot surgery
US7862531Jun 25, 2004Jan 4, 2011Optonol Ltd.Flow regulating implants
US7871440Dec 11, 2006Jan 18, 2011Depuy Products, Inc.Unitary surgical device and method
US7875296Nov 29, 2007Jan 25, 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US7900484Nov 5, 2009Mar 8, 2011C.R. Bard, Inc.Prosthetic repair fabric
US7901461Dec 5, 2003Mar 8, 2011Ethicon, Inc.Viable tissue repair implants and methods of use
US7909886Mar 24, 2006Mar 22, 2011Organogenesis, Inc.Tissue repair fabric
US7914808 *Jul 15, 2002Mar 29, 2011Depuy Products, Inc.Hybrid biologic/synthetic porous extracellular matrix scaffolds
US7927619Apr 26, 2006Apr 19, 2011Promethean Surgical Devices LlcIn situ bulking composition
US7981862Jun 22, 2007Jul 19, 2011Biosurface Engineering Technologies, Inc.Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis
US7988717Nov 10, 2003Aug 2, 2011Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US7988720Jul 20, 2007Aug 2, 2011Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US8012205 *Jul 15, 2002Sep 6, 2011Depuy Products, Inc.Cartilage repair and regeneration device
US8016867Oct 28, 2004Sep 13, 2011Depuy Mitek, Inc.Graft fixation device and method
US8021414Jul 25, 2002Sep 20, 2011Boston Scientific Scimed, Inc.Intravascular stent
US8025896Jul 15, 2002Sep 27, 2011Depuy Products, Inc.Suspending pieces of a natural occurring extracellular tissue in a liquid and freeze drying for usage as repairing or regenerating body tissue; implantable
US8034016Dec 7, 2007Oct 11, 2011Optonol, Ltd.Flow regulating implants and methods of implanting
US8070792Mar 28, 2002Dec 6, 2011Boston Scientific Scimed, Inc.Stent
US8092529Jul 15, 2002Jan 10, 2012Depuy Products, Inc.Meniscus regeneration device
US8101570May 24, 2010Jan 24, 2012Biosurface Engineering Technologies, Inc.Single branch heparin-binding growth factor analogs
US8109896Feb 11, 2008Feb 7, 2012Optonol Ltd.Devices and methods for opening fluid passageways
US8114146Mar 15, 2004Feb 14, 2012Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US8137686Apr 20, 2004Mar 20, 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US8137702Dec 29, 2010Mar 20, 2012Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US8142489Sep 5, 2008Mar 27, 2012Boston Scientific Scimed, Inc.Flexible and expandable stent
US8163717Oct 6, 2009Apr 24, 2012Biosurface Engineering Technologies, Inc.Dual chain synthetic heparin-binding growth factor analogs
US8182545Jul 10, 2008May 22, 2012C.R. Bard, Inc.Implantable prosthesis
US8192763Jul 23, 2008Jun 5, 2012Cook Biotech IncorporatedProcessed ECM materials with enhanced component profiles
US8221780Jun 29, 2006Jul 17, 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US8226715Jun 30, 2003Jul 24, 2012Depuy Mitek, Inc.Scaffold for connective tissue repair
US8227411Feb 23, 2006Jul 24, 2012BioSurface Engineering Technologies, IncleFGF growth factor analogs
US8231930 *Aug 4, 2009Jul 31, 2012Maquet Cardiovascular, LlcSelf-aggregating protein compositions and use as sealants
US8282542Feb 24, 2009Oct 9, 2012Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US8313454Mar 26, 2010Nov 20, 2012Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US8337537Jul 15, 2002Dec 25, 2012Depuy Products, Inc.Device from naturally occurring biologically derived materials
US8348992Aug 21, 2001Jan 8, 2013Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US8366787Jun 14, 2002Feb 5, 2013Depuy Products, Inc.Hybrid biologic-synthetic bioabsorbable scaffolds
US8449561Feb 15, 2007May 28, 2013Depuy Mitek, LlcGraft fixation device combination
US8449597Nov 21, 2011May 28, 2013Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US8486086Nov 7, 2011Jul 16, 2013Optonol, LtdFlow regulating implant, method of manufacture, and delivery device
US8496970Feb 27, 2012Jul 30, 2013Depuy Mitek, LlcConformable tissue repair implant capable of injection delivery
US8541372Jan 3, 2011Sep 24, 2013Cook Biotech IncorporatedIsolated extracellular matrix material including subserous fascia
US8562665Dec 17, 2002Oct 22, 2013Boston Scientific Scimed, Inc.Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US8591930Apr 28, 2008Nov 26, 2013Cook Biotech IncorporatedGrowth factor modified extracellular matrix material preparation and methods for preparation and use thereof
US8617206Oct 4, 2010Dec 31, 2013Covidien LpWound closure device
US8628464Oct 2, 2012Jan 14, 2014Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US8637066Sep 21, 2010Jan 28, 2014Depuy Mitek, LlcBiocompatible scaffold for ligament or tendon repair
US8641775Feb 1, 2011Feb 4, 2014Depuy Mitek, LlcViable tissue repair implants and methods of use
US8663086Sep 28, 2010Mar 4, 2014Cook Biotech IncorporatedMedical reinforcement graft
US8663313Sep 22, 2011Mar 4, 2014Boston Scientific Scimed, Inc.Low strain high strength stent
US8691259Nov 16, 2005Apr 8, 2014Depuy Mitek, LlcReinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US8728147Dec 20, 2011May 20, 2014Boston Scientific LimitedLongitudinally flexible expandable stent
US8790388Mar 2, 2012Jul 29, 2014Boston Scientific Scimed, Inc.Stent with reduced profile
US8795384Jan 10, 2008Aug 5, 2014Cook Biotech IncorporatedImplantable devices useful for reinforcing a surgically created stoma
US8796212Jul 19, 2011Aug 5, 2014Biosurface Engineering Technologies, Inc.Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
US8801773Mar 26, 2012Aug 12, 2014Boston Scientific Scimed, Inc.Flexible and expandable stent
US20050232967Apr 20, 2004Oct 20, 2005Kladakis Stephanie MNonwoven tissue scaffold
US20090297692 *Aug 4, 2009Dec 3, 2009Maquet Cardiovascular, LlcSelf-aggregating protein compositions and use as sealants
US20100015868 *Jul 2, 2009Jan 21, 2010Philippe GravagnaReinforced composite implant
US20100174253 *Jun 11, 2008Jul 8, 2010Convatec Technologies Inc.Ostomy Appliance
USRE44501Aug 12, 2010Sep 17, 2013Smith & Nephew, Inc.Hindfoot nail
DE3503126A1 *Jan 30, 1985Aug 1, 1985Meadox Medicals IncArzneimittel abgebender kollagenbeschichteter synthetischer gefaessersatz
DE3503127A1 *Jan 30, 1985Aug 1, 1985Meadox Medicals IncKollagenbeschichteter synthetischer gefaessersatz
DE4128611A1 *Aug 28, 1991Mar 5, 1992Meadox Medicals IncAusfransfestes, selbsttragendes, gewobenes gefaessimplantat
DE4128611C3 *Aug 28, 1991Apr 18, 2002Meadox Medicals IncAusfransfestes, selbsttragendes, gewobenes Gefäßimplantat und Verfahren zu seiner Herstellung
EP0103005A1 *Feb 16, 1983Mar 21, 1984SCHENCK, Robert R.Method and apparatus for anastomosing blood vessels
EP0129428A2 *Jun 15, 1984Dec 27, 1984Robert Roy SchenkDevices for joining anatomical structures
EP0466105A2 *Jul 9, 1991Jan 15, 1992Corvita CorporationComposite biosynthetic graft
EP0587461A2 *Jun 14, 1993Mar 16, 1994Terumo Kabushiki KaishaArtificial blood vessel
EP0943345A1 *Nov 19, 1997Sep 22, 1999SHIMIZU, YasuhikoArtificial esophagus
WO1982001647A1 *Oct 30, 1981May 27, 1982Robert L KasterVascular graft
WO1983003536A1 *Apr 18, 1983Oct 27, 1983Massachusetts Inst TechnologyA multilayer bioreplaceable blood vessel prosthesis
WO1984000540A1 *Jul 28, 1983Feb 16, 1984Jolla Cancer Res FoundPolypeptide
WO1992003107A1Aug 27, 1991Mar 1, 1992Meadox Medicals IncSelf-supporting woven vascular graft
WO1998018408A1Oct 22, 1997May 7, 1998Bionix Implants OySurgical implant
WO2001080918A1Apr 25, 2000Nov 1, 2001Karen KelsoExpanded polytetrafluoroethylene vascular graft with coating
WO2003034945A1 *Oct 23, 2002May 1, 2003Sakai KatsukoArtificial vessel and process for producing the same
WO2004093932A1 *Apr 21, 2004Nov 4, 2004Verigen AgA seeded tear resistant scaffold
WO2011079976A1 *Oct 28, 2010Jul 7, 2011Biom'upComposite matrix
Classifications
U.S. Classification606/151, 427/398.1, 139/387.00R, 427/338, 623/1.38, 606/229
International ClassificationA61F2/04, A61L27/48, A61F2/06
Cooperative ClassificationA61F2/06, A61L27/48, A61F2/04
European ClassificationA61L27/48, A61F2/06, A61F2/04